CareDx: Michael Bell, Marcel Konrad
CareDx said that CFO Michael Bell has notified the company of his intent to resign, effective Dec. 31. The firm has appointed Marcel Konrad to serve as interim CFO, effective upon Bell's resignation.
Konrad has served as vice president and corporate controller at CareDx since August 2018. Prior to joining the company, he served in various capacities at Santen between November 2013 and July 2018, including as CFO for Santen USA, and as global head of R&D finance and CFO for Santen Ventures. Prior to that, Konrad worked for Novartis for nine years in both Switzerland and the US in various roles.
Molecular Assemblies: Phil Paik
Phil Paik has been appointed as VP of platform development at enzymatic DNA synthesis firm Molecular Assemblies. He joins the San Diego-based company from Illumina, where he was associate director of engineering. Prior to that, he was a founding member of Advanced Liquid Logic. He also served as senior microfluidics design engineer at ICx Technologies.
Biofidelity: Robert Osborne
Biofidelity has appointed Robert Osborne as its chief operating officer. Osborne previously served as senior VP of technology and assay development at Inivata. Prior to Inivata, Osborne served as principal staff scientist at the Wellcome Trust Sanger Institute, director of technology development at its spinout company, 14M Genomics, and director of research at Population Genetics Technologies.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.